Biopharmaceutical Conjugation
Pharmaceutical and biotech companies seek more targeted therapies and potentially more clinically efficacious drug. Creating a successful drug conjugate for the control of biopharmaceutical properties requires expertise in the design and selection of the drug, biopolymer and linker. With over 30 years focusing on complex API conjugate technologies, our bioconjugation-based drug discovery and development program can quickly assist clients in obtaining conjugated drugs that are more targeted and exponentially more powerful. From project scope analysis and problem solving proposal, to complex biopolymer production and assay development, we strive with competence and confidence to meet your demand for creating novel conjugates that can be quickly and cost-effectively added to your value chain. Bio-Synthesis, your partner in therapeutic drug innovation.
Integrated Solutions for Enhancing the Pipeline
Service Portfolios:
- Antibody-drug or toxin conjugate
- Glycopeptides, peptidomimetics, proteinmimetics or cyclodextrin-peptide-conjugates
- Peptide and peptide mimetic drug conjugate
- Carbohydrate-peptide conjugates
- Antisense and oligomimetic drug development
- Liposome conjugates
- Nanoparticle-aptamer bioconjugates
- Polymer-drug conjugates
To obtain further information regarding your diagnostic bioconjugation project, contact our National Customer Services Center at 800.227.0627 or contact us online with each inquiry to assist in meeting customer specifications.